USD 0.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | 15.26 Million USD | 1.01% |
2021 | 15.11 Million USD | 151.54% |
2020 | 6 Million USD | 6510.49% |
2019 | 90.9 Thousand USD | -54.35% |
2018 | 199.12 Thousand USD | -75.61% |
2017 | 816.42 Thousand USD | 39.84% |
2016 | 583.81 Thousand USD | 99.74% |
2015 | 292.28 Thousand USD | 127.13% |
2014 | 128.68 Thousand USD | 54.26% |
2013 | 83.42 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2022 Q3 | 14.22 Million USD | 2.72% |
2022 Q2 | 13.85 Million USD | 0.97% |
2022 FY | 15.26 Million USD | 1.01% |
2022 Q1 | 13.71 Million USD | -9.25% |
2022 Q4 | 15.26 Million USD | 7.31% |
2021 FY | 15.11 Million USD | 151.54% |
2021 Q1 | 6.39 Million USD | 6.47% |
2021 Q4 | 15.11 Million USD | -11.92% |
2021 Q2 | 17.25 Million USD | 169.74% |
2021 Q3 | 17.16 Million USD | -0.56% |
2020 FY | 6 Million USD | 6510.49% |
2020 Q1 | - USD | -100.0% |
2020 Q4 | 6 Million USD | 0.0% |
2019 FY | 90.9 Thousand USD | -54.35% |
2019 Q4 | 90.9 Million USD | 0.0% |
2018 FY | 199.12 Thousand USD | -75.61% |
2018 Q4 | -504 Thousand USD | 0.0% |
2017 FY | 816.42 Thousand USD | 39.84% |
2017 Q4 | -733 Thousand USD | 0.0% |
2016 FY | 583.81 Thousand USD | 99.74% |
2015 Q2 | 477.92 Thousand USD | 0.0% |
2015 Q4 | 292.28 Thousand USD | 0.0% |
2015 Q1 | 477.92 Thousand USD | 271.38% |
2015 Q3 | 292.28 Thousand USD | -38.84% |
2015 FY | 292.28 Thousand USD | 127.13% |
2014 Q3 | 128.68 Thousand USD | 0.0% |
2014 Q4 | 128.68 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 128.68 Thousand USD | 54.26% |
2013 FY | 83.42 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Bio Medica Corporation | 1.26 Million USD | -1103.073% |
Arrayit Corporation | 1 Million USD | -1426.106% |
Atlantic International Corp. | 4.43 Million USD | -244.133% |
Biocept, Inc. | 30.87 Million USD | 50.549% |
Bioqual, Inc. | 56.58 Million USD | 73.021% |
CardioGenics Holdings Inc | 231.93 Thousand USD | -6482.533% |
DermTech, Inc. | 121.93 Million USD | 87.479% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.635% |
HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 14.123% |
iMD Companies, Inc. | 190.13 Thousand USD | -7929.473% |
IDenta Corp. | 1.52 Million USD | -898.316% |
Interpace Biosciences, Inc. | 13.02 Million USD | -17.249% |
Integrative Health Technologies, Inc. | 8.25 Million USD | -85.012% |
InVitro International | 1.53 Million USD | -895.237% |
Lumos Diagnostics Holdings Limited | 26.83 Million USD | 43.114% |
Many Bright Ideas Technologies Inc. | 2312.00 USD | -660237.37% |
Medical Imaging Corp. | 4.19 Million USD | -264.226% |
NovelStem International Corp. | 2.25 Million USD | -577.165% |
Optigenex Inc. | 1.88 Million USD | -708.509% |
PharmChem, Inc. | 2.76 Million USD | -452.04% |
Proteome Sciences plc | 14.58 Million USD | -4.669% |
Response Genetics, Inc | 48.88 Million USD | 68.769% |
Rennova Health, Inc. | 20.57 Million USD | 25.79% |
RushNet, Inc. | 6.04 Million USD | -152.447% |
ScreenPro Security Inc. | 1.26 Million USD | -1110.361% |
Stella Diagnostics Inc. | 472.42 Thousand USD | -3131.638% |
StageZero Life Sciences Ltd. | 700.65 Thousand USD | -2078.97% |